176 related articles for article (PubMed ID: 3373306)
1. Iodine-131 uptake in inflammatory lung disease: a potential pitfall in treatment of thyroid carcinoma.
Höschl R; Choy DH; Gandevia B
J Nucl Med; 1988 May; 29(5):701-6. PubMed ID: 3373306
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer.
Samuel AM; Rajashekharrao B; Shah DH
J Nucl Med; 1998 Sep; 39(9):1531-6. PubMed ID: 9744337
[TBL] [Abstract][Full Text] [Related]
3. Radioiodine uptake by metastatic nonthyroidal adenocarcinoma of the lung in a patient with papillary thyroid carcinoma.
Sohn MH; Kim MW; Lim ST; Lee NR; Song EK; Yim CY
Clin Nucl Med; 2005 Apr; 30(4):269-70. PubMed ID: 15764888
[TBL] [Abstract][Full Text] [Related]
4. Metastatic follicular carcinoma of the thyroid: reappearance of radioiodine uptake.
Oyen WJ; Mudde AH; van den Broek WJ; Corstens FH
J Nucl Med; 1995 Apr; 36(4):613-5. PubMed ID: 7699452
[TBL] [Abstract][Full Text] [Related]
5. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays.
Schlumberger M; Arcangioli O; Piekarski JD; Tubiana M; Parmentier C
J Nucl Med; 1988 Nov; 29(11):1790-4. PubMed ID: 3183748
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of hepatic visualization on iodine-131 whole-body scan in patients with thyroid carcinoma.
Chung JK; Lee YJ; Jeong JM; Lee DS; Lee MC; Cho BY; Koh CS
J Nucl Med; 1997 Aug; 38(8):1191-5. PubMed ID: 9255147
[TBL] [Abstract][Full Text] [Related]
7. Diffuse 131I lung uptake in bronchiectasis: a potential pitfall in the follow-up of differentiated thyroid carcinoma.
Triggiani V; Moschetta M; Giagulli VA; Licchelli B; Guastamacchia E
Thyroid; 2012 Dec; 22(12):1287-90. PubMed ID: 23067330
[TBL] [Abstract][Full Text] [Related]
8. [Metastases of a medullary carcinoma of the thyroid (follicular variant). Diagnosis and therapy using radioiodine].
Ruhlmann J; Vogel J; Bockisch A; Biersack HJ
Dtsch Med Wochenschr; 1987 Jul; 112(30):1170-2. PubMed ID: 3608841
[TBL] [Abstract][Full Text] [Related]
9. Neck and whole-body scanning with 5-mCi dose of (123)I as diagnostic tracer in patients with well-differentiated thyroid cancer.
Gulzar Z; Jana S; Young I; Bukberg P; Yen V; Naddaf S; Abdel-Dayem HM
Endocr Pract; 2001; 7(4):244-9. PubMed ID: 11497474
[TBL] [Abstract][Full Text] [Related]
10. Differentiated thyroid cancer presenting with thyrotoxicosis due to functioning metastases.
Haq M; Hyer S; Flux G; Cook G; Harmer C
Br J Radiol; 2007 Feb; 80(950):e38-43. PubMed ID: 17495053
[TBL] [Abstract][Full Text] [Related]
11. Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer?
Fatourechi V; Hay ID; Mullan BP; Wiseman GA; Eghbali-Fatourechi GZ; Thorson LM; Gorman CA
Thyroid; 2000 Jul; 10(7):573-7. PubMed ID: 10958309
[TBL] [Abstract][Full Text] [Related]
12. [Iodine uptake in the chest in the follow-up of well-differentiated thyroid cancer].
García Alonso MP; Balsa Bretón MA; Paniagua Correa C; Castillejos Rodríguez L; Penín González FJ; Elviro Peña R; Ortega Valle A; Mariana Monguía A; Vásquez Tineo SI; Mendoza Paulini A; Pey Illera C
Rev Esp Med Nucl; 2011; 30(1):24-8. PubMed ID: 20863596
[TBL] [Abstract][Full Text] [Related]
13. [Experience with a high-dose therapy concept in metastatic differentiated thyroid cancer].
Grünwald F; Ruhlmann J; Ammari B; Knopp R; Hotze A; Biersack HJ
Nuklearmedizin; 1988 Dec; 27(6):266-71. PubMed ID: 3217257
[TBL] [Abstract][Full Text] [Related]
14. [Low dose radioiodine treatment of papillary thyroid carcinoma in a child--a case report].
Hsieh SH; Huang MJ; Kao PF; Huang BY; Huang HS
Changgeng Yi Xue Za Zhi; 1992 Dec; 15(4):220-5. PubMed ID: 1295658
[TBL] [Abstract][Full Text] [Related]
15. [Principles of radionuclide methods of diagnosing and treating primary thyroid cancer and its metastases].
Purizhanskiĭ II; Lushina LI; Lyzhina VD; Lisenkov PI
Med Radiol (Mosk); 1982 Oct; 27(10):61-6. PubMed ID: 7176859
[No Abstract] [Full Text] [Related]
16. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.
Durante C; Haddy N; Baudin E; Leboulleux S; Hartl D; Travagli JP; Caillou B; Ricard M; Lumbroso JD; De Vathaire F; Schlumberger M
J Clin Endocrinol Metab; 2006 Aug; 91(8):2892-9. PubMed ID: 16684830
[TBL] [Abstract][Full Text] [Related]
17. [Results of radioiodine therapy in 47 patients with distant metastases of differentiated thyroid carcinoma].
Miyamoto S; Kasagi K; Endo K; Iida Y; Hidaka A; Hatabu H; Konishi J
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Jul; 51(7):810-21. PubMed ID: 1891347
[TBL] [Abstract][Full Text] [Related]
18. A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments.
Leger AF; Pellan M; Dagousset F; Chevalier A; Keller I; Clerc J
Br J Radiol; 2005 May; 78(929):428-32. PubMed ID: 15845937
[TBL] [Abstract][Full Text] [Related]
19. The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma.
Lin JD; Kao PF; Chao TC
Br J Radiol; 1998 Mar; 71(843):307-13. PubMed ID: 9616241
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans.
Sabra MM; Grewal RK; Tala H; Larson SM; Tuttle RM
Thyroid; 2012 Sep; 22(9):877-83. PubMed ID: 22827641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
